DiaMedica Therapeutics (DMAC) Tax Rate (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Tax Rate came in at 0.07% in Q2 2026, up 1.0% on a YoY basis from 0.07% in Q2 2025, and up 0.96% quarter-over-quarter from 0.07% in Q1 2026.
Powered by 
Analysis
DiaMedica Therapeutics (DMAC) Tax Rate (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics (DMAC) has reported Tax Rate for 9 consecutive years, with 0.07% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate rose 1.0% year-over-year to 0.07%; the trailing twelve-month figure through Jun 2026 stood at 12.96% (up 57.0% YoY), and the FY2025 full-year result was 14.83%, down 15.0% from the prior year.
- Tax Rate rose to 0.07% in Q2 2026 per DMAC's latest filing, from 0.07% in the prior quarter.
- Across five years, Tax Rate topped out at 54.1% in Q4 2025 and bottomed at 1.1% in Q4 2022.
- Historically, Tax Rate has averaged 5.4% across 5 years, with a median of 0.13% in 2024.
- The sharpest annual moves came in 2022 and 2024: Tax Rate sank 38 bps in 2022, then jumped 4688 bps in 2024.
- Over 5 years, Tax Rate stood at 1.1% in 2022, then surged by 61 bps to 0.43% in 2023, then soared by 10950 bps to 46.45% in 2024, then climbed by 16 bps to 54.1% in 2025, then plunged by 100 bps to 0.07% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.07%, 0.07%, and 54.1% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 26.36% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -16.71% |
| 10 | DiaMedica Therapeutics | 364.00 Mn | 364.00 Mn | - | -0.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.07% |
| Mar 31, 2026 | -0.07% |
| Dec 31, 2025 | 54.10% |
| Sep 30, 2025 | -0.07% |
| Jun 30, 2025 | -0.08% |
| Mar 31, 2025 | -0.08% |
| Dec 31, 2024 | 46.45% |
| Sep 30, 2024 | -0.11% |
| Jun 30, 2024 | -0.14% |
| Mar 31, 2024 | -0.14% |
| Dec 31, 2023 | -0.43% |
| Sep 30, 2023 | -0.16% |
| Jun 30, 2023 | -0.16% |
| Mar 31, 2023 | -0.13% |
| Dec 31, 2022 | -1.10% |
| Sep 30, 2022 | -0.23% |
| Jun 30, 2022 | -0.21% |
| Mar 31, 2022 | -0.20% |
| Dec 31, 2021 | -0.71% |
| Sep 30, 2021 | -0.20% |